|
Real-time Estimate
Cboe BZX
07:47:33 05/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 28.04 USD | +3.37% |
|
+6.08% | +4.29% |
| 19/08 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 07/08 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 1.15B 1.03B 943M 857M 1.61B 109B 1.65B 11.27B 4.52B 57.7B 4.33B 4.24B 183B | P/E 2026 * |
12.5x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 1.3B 1.19B 1.08B 2.04B 138B 2.08B 14.26B 5.72B 73.01B 5.48B 5.36B 231B | EV / Sales 2026 * |
1.95x | EV / Sales 2027 * | 1.71x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Börse Stuttgart
| 29A | Delayed | |
|
Boerse Muenchen
| 29A | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Tradegate
| 29A | Real-time |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | +3.37% | ||
| 1 week | +6.08% | ||
| Current month | +0.76% | ||
| 1 month | +10.09% | ||
| 3 months | +40.35% | ||
| 6 months | +22.82% | ||
| Current year | +4.29% |
| 1 week | 26.45 |  | 28.56 |
| 1 month | 24.62 | | 28.56 |
| Current year | 16.64 | | 29.52 |
| 1 year | 16.64 | | 29.52 |
| 3 years | 16.64 | | 65.92 |
| 5 years | 16.64 | | 67.66 |
| 10 years | 12.05 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 29/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 29/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/9/26 | Sell | Chief Financial Officer | -4,139 | 0.0097% | ||
| 16/9/26 | Exercice | Chief Technology Officer | 30,000 | 0.0705% | ||
| 2/9/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.37% | +6.08% | +10.57% | -40.36% | 1.15B | |
| +0.82% | +10.40% | +56.83% | +138.95% | 1,255B | |
| +3.96% | +2.19% | +48.22% | +82.58% | 641B | |
| +2.66% | +2.60% | +35.92% | +107.82% | 505B | |
| +1.25% | -0.78% | +52.56% | +66.87% | 381B | |
| +3.76% | +6.10% | +78.31% | +43.31% | 357B | |
| +2.10% | +4.26% | +34.93% | +61.10% | 303B | |
| +1.92% | +9.37% | +13.43% | +36.55% | 286B | |
| +3.84% | +6.28% | +61.85% | +76.01% | 249B | |
| +4.35% | +9.88% | +42.22% | +115.59% | 208B | |
| Average | +2.72% | +3.26% | +43.48% | +68.84% | 418.64B | |
| Weighted average by Cap. | +2.29% | +3.90% | +49.44% | +94.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 747M 666M 611M 555M 1.04B 70.63B 1.07B 7.3B 2.93B 37.38B 2.81B 2.75B 118B | 784M 699M 641M 582M 1.09B 74.09B 1.12B 7.66B 3.07B 39.21B 2.94B 2.88B 124B |
| Net income | 99.32M 88.5M 81.16M 73.76M 139M 9.39B 142M 970M 389M 4.97B 373M 365M 15.74B | 115M 103M 94.32M 85.72M 161M 10.91B 165M 1.13B 452M 5.77B 433M 424M 18.29B |
| Net Debt | 306M 273M 250M 227M 427M 28.92B 437M 2.99B 1.2B 15.31B 1.15B 1.12B 48.49B | 190M 169M 155M 141M 265M 17.94B 271M 1.85B 743M 9.49B 712M 697M 30.08B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/11/26 | USD 27.99 | +3.19% | 423,942 |
| 03/11/26 | USD 27.12 | +0.33% | 550,213 |
| 02/11/26 | USD 27.03 | -2.49% | 497,703 |
| 30/10/26 | USD 27.72 | +2.93% | 664,507 |
| 29/10/26 | USD 26.93 | +2.28% | 371,414 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions
